SCHEMBL20936330

SCHEMBL20936330

CC(Sc1nnc(C2CC2)n1-c1ccccc1)C(=O)Nc1sc2c(c1C(N)=O)CCC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.53
ALDH1A1 P00352 8/20 0.52
HPGD P15428 4/20 0.52
HSD17B10 Q99714 4/20 0.50
LMNA P02545 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
POLB P06746 3/20 0.50
MAPT P10636 3/20 0.50
NPSR1 Q6W5P4 2/20 0.50
KDM4E B2RXH2 2/20 0.50
USP2 O75604 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
PTPN7 P35236 1/20 0.50
MCL1 Q07820 1/20 0.50
KMT2A Q03164 4/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
MEN1 O00255 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30434330 0.91 L3MBTL1 (0.51) L3MBTL1ALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL25716301 0.89 L3MBTL1 (0.55) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL20548011 0.87 ALDH1A1 (0.58) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL20936251 0.87 ALDH1A1 (0.51) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL25416954 0.86 L3MBTL1 (0.48) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL21082571 0.85 ALDH1A1 (0.56) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL20936195 0.85 ALDH1A1 (0.55) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL21045523 0.85 ALDH1A1 (0.52) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL20936190 0.84 ALDH1A1 (0.58) L3MBTL1ALDH1A1HPGDHSD17B10LMNA
SCHEMBL20936236 0.84 HTT (0.52) L3MBTL1ALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081835-A1 EXPANDING T-CELL USING MITOFUSIN ACTIVATORS AND USES IN CANCER THERAPIES EMORY UNIVERSITY (US) 2023-05-11 WO claimed
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2020-09-10 US claimed
US-12409157-B2 Mitofusin activators and methods of use thereof DORN, GERALD W., II, DR. 2025-09-09 US disclosed
US-20250099404-A1 TRANS-4-HYDROXYCYCLOHEXYL PHENYL AMIDE MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MITOCHONDRIA IN MOTION, INC. (US) 2025-03-27 US disclosed
US-20240366540-A1 MITOFUSIN INHIBITORS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE 2024-11-07 US disclosed
EP-4444284-A1 MITOFUSIN INHIBITORS AND USES THEREOF Albert Einstein College of Medicine (US) 2024-10-16 EP disclosed
US-20240082180-A1 MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF DORN, GERALD W., II, DR. 2024-03-14 US disclosed
US-11813268-B2 Mitofusin activators and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-11-14 US disclosed
US-11813268-B2 Mitofusin activators and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-11-14 US disclosed
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2023-09-19 US disclosed
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2023-09-19 US disclosed
US-10844023-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2020-11-24 US disclosed
US-10844023-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2020-11-24 US disclosed
US-20200345668-A1 TRANS-4-HYDROXYCYCLOHEXYL PHENYL AMIDE MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MITOCHONDRIA EMOTION, INC. (US) 2020-11-05 US disclosed
US-20200345669-A1 MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MITOCHONDRIA EMOTION, INC. (US) 2020-11-05 US disclosed
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2020-09-10 US disclosed
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2020-09-10 US disclosed
US-20190169138-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2019-06-06 US disclosed
US-20190169138-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2019-06-06 US disclosed
WO-2019079243-A1 MITOFUSIN ACTIVATORS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2019-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240082180-A1 MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MFN2, FIS1, TFB2M L3MBTL1 2509/4885ALDH1A1 3892/4885HPGD 1611/4885
US-20190169138-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF MFN2, FIS1, RHOT2 L3MBTL1 1995/4885ALDH1A1 4127/4885HPGD 1662/4885
US-20200345668-A1 TRANS-4-HYDROXYCYCLOHEXYL PHENYL AMIDE MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MFN2, TFB2M, HADHA L3MBTL1 1683/4885ALDH1A1 3019/4885HPGD 482/4885
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof MFN2, FIS1, RHOT2 L3MBTL1 1995/4885ALDH1A1 4127/4885HPGD 1662/4885
US-11813268-B2 Mitofusin activators and uses thereof MFN2, TFB2M, PCK2 L3MBTL1 1742/4885ALDH1A1 3698/4885HPGD 853/4885
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF MFN2, FIS1, RHOT2 L3MBTL1 1995/4885ALDH1A1 4127/4885HPGD 1662/4885
US-10844023-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof MFN2, FIS1, RHOT2 L3MBTL1 1995/4885ALDH1A1 4127/4885HPGD 1662/4885
US-20200345669-A1 MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MFN2, FIS1, TFB2M L3MBTL1 2509/4885ALDH1A1 3892/4885HPGD 1611/4885
US-20250099404-A1 TRANS-4-HYDROXYCYCLOHEXYL PHENYL AMIDE MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF MFN2, TFB2M, HADHA L3MBTL1 1683/4885ALDH1A1 3019/4885HPGD 482/4885
US-12409157-B2 Mitofusin activators and methods of use thereof MFN2, FIS1, TFB2M L3MBTL1 2509/4885ALDH1A1 3892/4885HPGD 1611/4885
US-20240366540-A1 MITOFUSIN INHIBITORS AND USES THEREOF TFAM, MFN2, MAVS L3MBTL1 2456/4885ALDH1A1 2950/4885HPGD 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.